Bank of New York Mellon’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.25B | Buy |
3,222,787
+377,507
| +13% | +$140M | 0.2% | 87 |
|
|
2026
Q1 | $833M | Buy |
2,845,280
+436,576
| +18% | +$143M | 0.15% | 129 |
|
|
2025
Q4 | $844M | Buy |
2,408,704
+1,065,065
| +79% | +$360M | 0.15% | 129 |
|
|
2025
Q3 | $434M | Buy |
1,343,639
+42,821
| +3% | +$13.3M | 0.08% | 223 |
|
|
2025
Q2 | $506M | Sell |
1,300,818
-104,255
| -7% | -$41.9M | 0.1% | 195 |
|
|
2025
Q1 | $611M | Sell |
1,405,073
-48,141
| -3% | -$19.3M | 0.12% | 165 |
|
|
2024
Q4 | $536M | Sell |
1,453,214
-156,230
| -10% | -$65.4M | 0.1% | 190 |
|
|
2024
Q3 | $837M | Sell |
1,609,444
-56,143
| -3% | -$30M | 0.16% | 124 |
|
|
2024
Q2 | $903M | Sell |
1,665,587
-44,557
| -3% | -$23.6M | 0.17% | 110 |
|
|
2024
Q1 | $887M | Sell |
1,710,144
-100,518
| -6% | -$50M | 0.17% | 111 |
|
|
2023
Q4 | $854M | Sell |
1,810,662
-124,037
| -6% | -$57.4M | 0.17% | 116 |
|
|
2023
Q3 | $842M | Sell |
1,934,699
-9,351
| -0.5% | -$4.24M | 0.19% | 108 |
|
|
2023
Q2 | $864M | Sell |
1,944,050
-232,195
| -11% | -$107M | 0.18% | 112 |
|
|
2023
Q1 | $1B | Buy |
2,176,245
+37,463
| +2% | +$17.8M | 0.22% | 101 |
|
|
2022
Q4 | $1.1B | Buy |
2,138,782
+105,655
| +5% | +$53.6M | 0.25% | 87 |
|
|
2022
Q3 | $924M | Sell |
2,033,127
-269
| -0% | -$129K | 0.22% | 93 |
|
|
2022
Q2 | $981M | Buy |
2,033,396
+59,694
| +3% | +$29.5M | 0.22% | 92 |
|
|
2022
Q1 | $970M | Sell |
1,973,702
-21,507
| -1% | -$9.83M | 0.19% | 104 |
|
|
2021
Q4 | $925M | Sell |
1,995,209
-5,357
| -0.3% | -$2.25M | 0.17% | 116 |
|
|
2021
Q3 | $746M | Sell |
2,000,566
-82,638
| -4% | -$31.4M | 0.15% | 130 |
|
|
2021
Q2 | $795M | Sell |
2,083,204
-19,785
| -0.9% | -$7.56M | 0.15% | 122 |
|
|
2021
Q1 | $755M | Sell |
2,102,989
-144,346
| -6% | -$46.4M | 0.15% | 121 |
|
|
2020
Q4 | $722M | Sell |
2,247,335
-134,870
| -6% | -$41.4M | 0.16% | 121 |
|
|
2020
Q3 | $640M | Sell |
2,382,205
-16,215
| -0.7% | -$4.36M | 0.16% | 118 |
|
|
2020
Q2 | $631M | Sell |
2,398,420
-98,710
| -4% | -$26.3M | 0.17% | 115 |
|
|
2020
Q1 | $567M | Buy |
2,497,130
+24,952
| +1% | +$6.8M | 0.19% | 107 |
|
|
2019
Q4 | $747M | Sell |
2,472,178
-3,746
| -0.2% | -$1.03M | 0.19% | 99 |
|
|
2019
Q3 | $594M | Sell |
2,475,924
-106,716
| -4% | -$29.2M | 0.16% | 118 |
|
|
2019
Q2 | $729M | Buy |
2,582,640
+219,003
| +9% | +$59.8M | 0.2% | 99 |
|
|
2019
Q1 | $678M | Buy |
2,363,637
+151,052
| +7% | +$43.7M | 0.19% | 100 |
|
|
2018
Q4 | $581M | Sell |
2,212,585
-198,256
| -8% | -$54.5M | 0.18% | 107 |
|
|
2018
Q3 | $661M | Sell |
2,410,841
-6,191
| -0.3% | -$1.61M | 0.17% | 112 |
|
|
2018
Q2 | $575M | Sell |
2,417,032
-36,048
| -1% | -$8.35M | 0.16% | 124 |
|
|
2018
Q1 | $539M | Buy |
2,453,080
+75,102
| +3% | +$17.6M | 0.15% | 130 |
|
|
2017
Q4 | $535M | Buy |
2,377,978
+277,169
| +13% | +$59M | 0.14% | 147 |
|
|
2017
Q3 | $399M | Sell |
2,100,809
-31,870
| -1% | -$6.07M | 0.11% | 187 |
|
|
2017
Q2 | $401M | Sell |
2,132,679
-123,904
| -5% | -$22.3M | 0.11% | 181 |
|
|
2017
Q1 | $373M | Sell |
2,256,583
-50,619
| -2% | -$8.05M | 0.1% | 201 |
|
|
2016
Q4 | $332M | Sell |
2,307,202
-140,183
| -6% | -$18.8M | 0.1% | 222 |
|
|
2016
Q3 | $307M | Sell |
2,447,385
-39,265
| -2% | -$5.07M | 0.09% | 239 |
|
|
2016
Q2 | $327M | Sell |
2,486,650
-101,600
| -4% | -$13.9M | 0.1% | 208 |
|
|
2016
Q1 | $360M | Sell |
2,588,250
-262,700
| -9% | -$35.1M | 0.11% | 195 |
|
|
2015
Q4 | $398M | Sell |
2,850,950
-1,218,457
| -30% | -$168M | 0.12% | 176 |
|
|
2015
Q3 | $570M | Buy |
4,069,407
+160,350
| +4% | +$24.1M | 0.17% | 118 |
|
|
2015
Q2 | $642M | Sell |
3,909,057
-183,652
| -4% | -$29.3M | 0.18% | 118 |
|
|
2015
Q1 | $632M | Sell |
4,092,709
-126,195
| -3% | -$18M | 0.16% | 128 |
|
|
2014
Q4 | $530M | Sell |
4,218,904
-61,572
| -1% | -$7.61M | 0.14% | 154 |
|
|
2014
Q3 | $512M | Sell |
4,280,476
-15,770
| -0.4% | -$1.81M | 0.14% | 150 |
|
|
2014
Q2 | $462M | Buy |
4,296,246
+1,027
| +0% | +$106K | 0.12% | 171 |
|
|
2014
Q1 | $428M | Buy |
4,295,219
+125,266
| +3% | +$11.3M | 0.12% | 176 |
|
|
2013
Q4 | $385M | Buy |
4,169,953
+806,940
| +24% | +$71.7M | 0.11% | 191 |
|
|
2013
Q3 | $281M | Sell |
3,363,013
-5,725
| -0.2% | -$491K | 0.08% | 249 |
|
|
2013
Q2 | $276M | Buy |
+3,368,738
| New | +$252M | 0.09% | 232 |
|
Other funds holding ELV
N
Bank of New York Mellon's ELV Position: Q2 2026 in Review
Bank of New York Mellon increased its Elevance Health (ELV) stake by 13% in Q2 2026, buying an estimated $140M and bringing the position to 3,222,787 shares worth $1.25B. The position accounts for 0.2% of the portfolio, ranked #87.
Bank of New York Mellon first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. 1,107 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Bank of New York Mellon held 3,222,787 shares of Elevance Health worth $1.25B as of Q2 2026.
- Bank of New York Mellon bought 377,507 Elevance Health shares in Q2 2026, an estimated $140M.
- Elevance Health made up 0.2% of Bank of New York Mellon's portfolio in Q2 2026, its #87 holding.
- Bank of New York Mellon first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- 1,107 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.